Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension
| Image |  |
|---|---|
| Description | scientific article published on 08 May 2019 |
| Author/s |
author: Haji Akber Aisa Zhen Wang Jingshan Shen Weiliang Zhu Yechun Xu Zhijian Xu |
| Publication date | May 8, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |